Assessing the Benefits & Challenges of Intravenous Delivery of Oncolytic Viruses
Time: 11:00 am
day: Day One
Details:
- How can we continue to deliver the virus intravenously?
- How can we overcome the body clearing the virus when delivered intravenously?
- What is the best way to conceal the virus in the bloodstream to avoid clearing and allowing it to cross into the tumor?
- What are the strategies to enhance viral circulation, evasion of neutralizing antibodies, and tumor tropism?
